Panacea Biotec
India - New DelhiBiotechnology
Focus: Panacea Biotec is an India-based biotechnology company specializing in differentiated generics, vaccines, and biosimilars across infectious diseases and vaccines. The company operates as a mid-cap generics and biotech player with a focused therapeutic portfolio.
Profile data last refreshed 9h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Panacea Biotec
AI assessmentNot HiringNo open roles listed right now. Follow Panacea Biotec to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Panacea Biotec's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
10 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Post-LOE
Immunosuppressant ANDA-approved generic with durable transplant indications; post-LOE status indicates mature revenue plateau.
Help build intelligence for Panacea Biotec
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.